Abstract:A new homogeneous electrochemical sensing system was developed for sensitive detection of microRNA-21 (miRNA-21) based on target-induced glucose release from propylamine-functionalized mesoporous silica nanoparticle (MSN) with glucometer readout. Glucose molecules (as the signal tracers) were initially gated into the pores through the interaction of the negatively charged anchor DNA with the aminated MSN. Upon addition of target miRNA, the analyte competitively hybridized with anchor DNA to form the RNA-DNA du… Show more
“…In fact, the PGM electrochemical readout [44][45][46][47] is living a second life as it enables the detection of nonglucose targets ranging from metal ion and small molecules to pathogens, proteins, and miRNAs. [48,49] PGMs have been coupled with biosensors for miRNAs by means of different recognition elements (e.g., invertase and amylase) and signal amplification methods (e.g., nanomaterials, hydrogels, DNAzyme) while employing glucose as signal tracer: [50][51][52] the combination of DNAzyme and invertase has allowed the miRNA-21 detection down to 68 fM in urine samples (Figure 3c). [34] In this case, the recognition oligonucleotides were immobilized on magnetic beads allowing to preconcentrate the target, to remove possible interferences and to prevent nonspecific adsorption by simply performing adequate washing steps of the beads (after incubation with the sample and prior to run the measurements).…”
Section: Poc Testing For Mirnas Detectionmentioning
Point‐of‐care (PoC) testing is revolutionizing the healthcare sector improving patient care in daily hospital practice and allowing reaching even remote geographical areas. In the frame of cancer management, the design and validation of PoC enabling the non‐invasive, rapid detection of cancer markers is urgently required to implement liquid biopsy in clinical practice. Therefore, focusing on stable blood‐based markers with high‐specificity, such as microRNAs, is of crucial importance. In this work, we highlight the potential impact of circulating microRNAs detection on cancer management and the development of PoC testing devices, especially for low‐income countries. A detailed discussion about the challenges that should be faced to promote the technological transfer and clinical use of these tools has been added, to provide the readers with a complete overview of potentialities and current limitations.
“…In fact, the PGM electrochemical readout [44][45][46][47] is living a second life as it enables the detection of nonglucose targets ranging from metal ion and small molecules to pathogens, proteins, and miRNAs. [48,49] PGMs have been coupled with biosensors for miRNAs by means of different recognition elements (e.g., invertase and amylase) and signal amplification methods (e.g., nanomaterials, hydrogels, DNAzyme) while employing glucose as signal tracer: [50][51][52] the combination of DNAzyme and invertase has allowed the miRNA-21 detection down to 68 fM in urine samples (Figure 3c). [34] In this case, the recognition oligonucleotides were immobilized on magnetic beads allowing to preconcentrate the target, to remove possible interferences and to prevent nonspecific adsorption by simply performing adequate washing steps of the beads (after incubation with the sample and prior to run the measurements).…”
Section: Poc Testing For Mirnas Detectionmentioning
Point‐of‐care (PoC) testing is revolutionizing the healthcare sector improving patient care in daily hospital practice and allowing reaching even remote geographical areas. In the frame of cancer management, the design and validation of PoC enabling the non‐invasive, rapid detection of cancer markers is urgently required to implement liquid biopsy in clinical practice. Therefore, focusing on stable blood‐based markers with high‐specificity, such as microRNAs, is of crucial importance. In this work, we highlight the potential impact of circulating microRNAs detection on cancer management and the development of PoC testing devices, especially for low‐income countries. A detailed discussion about the challenges that should be faced to promote the technological transfer and clinical use of these tools has been added, to provide the readers with a complete overview of potentialities and current limitations.
“…Using more porous materials amplified the EC signals as a result of higher loading capacity for redox components. 377 In this subsection, we discussed miR-21 detecting biosensors as a noninvasive approach for BC detection.…”
Section: Mir-21mentioning
confidence: 99%
“…In this procedure, the EC readouts are always increased. Using more porous materials amplified the EC signals as a result of higher loading capacity for redox components 377 …”
Breast cancer is categorized as the most widespread cancer type among women globally. On-time diagnosis can decrease the mortality rate by making the right decision in the therapy procedure. These features lead to a reduction in medication time and socioeconomic burden. The current review article provides a comprehensive assessment for breast cancer diagnosis using nanomaterials and related technologies. Growing use of the nano/biotechnology domain in terms of electrochemical nanobiosensor designing was discussed in detail. In this regard, recent advances in nanomaterial applied for amplified biosensing methodologies were assessed for breast cancer diagnosis by focusing on the advantages and disadvantages of these approaches. We also monitored designing methods, advantages, and the necessity of suitable (nano) materials from a statistical standpoint.The main objective of this review is to classify the applicable biosensors based on breast cancer biomarkers.With numerous nano-sized platforms published for breast cancer diagnosis, this review tried to collect the most suitable methodologies for detecting biomarkers and certain breast cancer cell types.
“…Deng and his colleagues invented an electrochemical device fully focused on propylamine functionalized mesoporous silica nanoparticles and glucose release caused by a target [71]. With a DL of 19 pM [71], the whole method allowed for the elimination of time-consuming labeling and repeated washing operations. There have been a variety of studies that have been conducted to detect miRNA155.…”
Section: Multiple Breast Cancer Biomarker Detectionmentioning
In the era of nanotechnology, researchers are implementing point to care service to cancer patients to detect malignancy beforehand and to reduce the mortality rate of cancers. Cancer is known to be the most fatal disease among all other diseases and the survivability from cancer is quite impossible if the stage of the cancer is an advanced level. Though the early detection of cancer can increase the chances of survival with a double fold. Biosensor is a part of nanotechnology which is capable to provide point to care service in the field of medicine. With the rising number of cancer occurrences being identified around the world and the increasing number of deaths because of the identification of advanced cancer, biosensors can play a significant part in the early detection of cancer. New molecular methods, including as genomic and proteomic approaches, are increasingly being used to study patient molecular profiles. When such diagnosis method is paired with bioinformatics tools, they generate new data that can be used to discover new disease biomarkers. Finding precise and sensitive indicators that are corelated to a specific disease, as with many other diseases, can be challenging. Furthermore, the concentration of biomarkers in biological fluids varies according to illness states and phases. Peptides, proteins, up or down regulated expression of gene markers, and gene alternation are all examples of molecular markers that are commonly used to diagnose cancer. In this article, we have highlighted six different deadliest cancers such as Ovarian, Breast, Prostrate, Lung, Colorectal and Liver cancer. The article contains distinct types of biomarkers which are normally found in these kinds of cancer and generally used as a potential diagnostic target in the medicine field. The article mainly summarized the application of different types of biosensors devices in the detection of the mostly found biomarkers in the above cancer types.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.